Table 1. Tumor incidence (%) for pBABE and IL-8 cl19 8505c xenotransplants treated or not with Reparixin.
Tumor Incidence (%) | ||
---|---|---|
Vehicle | Reparixin | |
8505c pBABE | 66,7 | 10* |
8505c IL-8 Cl19 | 90 | 50* |
* P < 0.05 compared to the relative vehicle-treated group of mice.